Clinical Trials in North Carolina

Showing 2741-2760 of 9,731 trials

SG2501 Safety Study in Subjects with Relapsed or Refractory Hematological Malignancies and Lymphoma.

NCT05293912

This is a phase Ia/Ib, first-in-Human, open-Label, multicenter, dose escalation and dose expansion study designed to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, immunogenicity, and preliminary efficacy of SG2501 in subjects with relapsed or refractory hematological malignancies and lymphoma.

Hematological MalignancyLymphoma

Hangzhou Sumgen Biotech Co., Ltd.2 participantsStarted Mar 2023

Atlanta, Georgia, United States • Hackensack, New Jersey, United States • Hawthorne, New York, United States +5 more locations

COMPLETEDNA41 miles

BIOTRONIK Conduction System Pacing With the Solia Lead

NCT05251363

The purpose of the BIO-CONDUCT study is to demonstrate the safety and effectiveness of the BIOTRONIK Solia S pacing lead when implanted in the left bundle branch (LBB) area. Safety will be assessed by evaluating serious adverse device effects that occur through 3 months post-implant. Efficacy will be assessed by evaluating implant success rate.

BradycardiaAtrioventricular BlockLeft Bundle-Branch Block+1 more

Biotronik, Inc.194 participantsStarted Dec 2022

Phoenix, Arizona, United States • Ventura, California, United States • Washington D.C., District of Columbia, United States +11 more locations

SG2501 Safety Study in Subjects with Relapsed or Refractory Hematological Malignancies and Lymphoma.

BIOTRONIK Conduction System Pacing With the Solia Lead

Find Trials by Condition in North Carolina

Study of KeraStat Cream for Radiation Dermatitis During Head and Neck Radiotherapy

Identifying Predictors of Poor Health-Related Quality-of-Life Among Pediatric Hematopoietic Stem Cell Donors

Evaluation of Visceral Function Following Endovascular Aortic Aneurysm Repair Using Branched Stent- Grafts

Clinical Trial to Evaluate Safety and Efficacy of CCX168 in ANCA-Associated Vasculitis

PF-06863135 As Single Agent And In Combination With Immunomodulatory Agents In Relapse/Refractory Multiple Myeloma

A Study of Etigilimab and Nivolumab in Participants With Locally Advanced or Metastatic Tumors

EVAS2 IDE Prospective, Multicenter, Single Arm Safety and Effectiveness Confirmatory Study

Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT411

Safety, PK, PD, Clinical Activity of KT-333 in Adult Patients With Refractory Lymphoma, Large Granular Lymphocytic Leukemia, Solid Tumors

p53 Suppressor Activation in Recurrent High Grade Serous Ovarian Cancer, a Phase Ib/II Study of Systemic Carboplatin Combination Chemotherapy With or Without APR-246

Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccine MRT5410 in Adult Participants 18 Years of Age and Older

A Clinical Effectiveness Study Examining the Efficacy and Safety of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD)

A Study of LY3561774 in Participants With Mixed Dyslipidemia

A Multicenter Patient Registry on Outcomes From Cryoanalgesia of the Intercostal Nerves

A Study to Evaluate the Safety of mRNA-0184 in Participants With Heart Failure

A Study to Assess the Efficacy, Safety, and Tolerability of KPL-716 in Reducing Pruritus in Chronic Pruritic Diseases

Pivotal, Clinical Study for the Accuracy Evaluation of the IdentiClone Dx TRG Assay

A Study of JR-171 in Patients With Mucopolysaccharidosis I